FDA药品溶出方法数据库
(FDA-Recommended Dissolution Methods Database)
药品通用名称 剂型 USP溶出装置 速度 溶出介质 介质体积 建议取样时间(分钟) 更新日期
Aspirin/ Omeprazole Tablet (Delayed Release) I (Basket) 100 Acid Stage: 0.1 N HCl (degassed); Buffer Stage: Phosphate Buffer, pH 6.8 (degassed) Acid Stage: 900; Buffer Stage: 900 Acid Stage:120; Buffer Stage:10, 20, 30, 45, 60 and 75 2016/12/22
Aspirin/Butalbital/Caffeine Capsule Develop a dissolution method 2024/01/03
Aspirin/Butalbital/Caffeine Tablet Develop a dissolution method 2024/01/03
Aspirin/Butalbital/Caffeine/Codeine Phosphate Capsule Develop a dissolution method 2024/01/03
Aspirin/Caffeine/Orphenadrine Citrate Tablet Develop a dissolution method 2023/09/15
Aspirin/Dipyridamole Capsule I (Basket) 100 0.01 N HCl for first hour, 0.1 M Phosphate Buffer, pH 5.5, thereafter 0-1 hrs: 900 mL. 900 mL thereafter Acid: 10, 20, 30, 45 and 60 min; Buffer:1, 2, 5, and 7 hours 2007/10/09
Aspirin/Hydrocodone Bitartrate Tablet II (Paddle) 75 Acetate Buffer, pH 4.5 900 10, 20, 30, 45, 60 and 90 2004/01/15
Aspirin/Meprobamate Tablet Develop a dissolution method 2023/09/15
Aspirin/Methocarbamol Tablet Develop a dissolution method 2023/09/15
Aspirin/Oxycodone HCl Tablet Refer to USP 2010/01/15
Atazanavir Sulfate Capsule II (Paddle) 50 0.025 N HCl 1000 10, 20, 30 and 45 2006/01/20
Atazanavir Sulfate/ Cobicistat Tablet II (Paddle) 75 0.05 M Citrate Buffer (pH 2.8) 1000 Atazanavir: 10, 15, 20, 30 and 45; Cobicistat: 5, 10, 15, 20 and 30 2015/12/24
Atenolol Tablet Refer to FDA's Dissolution Guidance, 2018 2020/07/02
Atenolol/Chlorthalidone Tablet Refer to USP 2014/02/14
Atogepant Tablet II (Paddle) 75 0.1 N HCl 500 5, 10, 15, 20, 30, 45 and 60 2026/01/28
Atomoxetine HCl Capsule Refer to FDA's Dissolution Guidance, 2018 2020/07/02
Atorvastatin Calcium Tablet II (Paddle) 75 0.05 M Phosphate buffer, pH 6.8 900 5, 10, 15 and 30 2004/01/15
Atorvastatin Calcium Suspension II (Paddle) 75 0.05 M Phosphate Buffer, pH 6.8 900 5, 10, 15 and 30 2024/05/31
Atorvastatin Calcium/Ezetimibe Tablet II (Paddle), with option to use a sinker for 20/10 mg strength 75 Phosphate buffer, pH 6.8 with 0.2% w/v Tween 80 900 5, 10, 15, 20, 30 and 45 2014/05/15
Atovaquone Tablet II (Paddle) 50 40% isopropanol buffered to pH 8.0 with potassium dihydrogen phosphate 900 10, 20, 30, 45, 60 and 90 2007/06/18

数据库说明:

当前数据更新日期:2026年04月15日。
©2006-2026 DrugFuture->FDA-Recommended Dissolution Methods Database